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ABSTRACT
NeuroPred is a web application designed to pre-
dict cleavage sites at basic amino acid locations
in neuropeptide precursor sequences. The user can
study one amino acid sequence or multiple
sequences simultaneously, selecting from several
prediction models and optional, user-defined func-
tions. Logistic regression models are trained on
experimentally verified or published cleavage data
from mollusks, mammals and insects, and amino
acid motifs reported to be associated with cleavage.
Confidence interval limits of the probabilities of
cleavage indicate the precision of the predictions;
these predictions are transformed into cleavage or
non-cleavage events according to user-defined
thresholds. In addition to the precursor sequence,
NeuroPred accepts user-specified cleavage informa-
tion, providing model accuracy statistics based on
observed and predicted cleavages. Neuropred also
computes the mass of the predicted peptides, includ-
ing user-selectable post-translational modifications.
The resulting mass list aids the discovery and
confirmation of new neuropeptides using mass
spectrometry techniques. The NeuroPred applica-
tion, manual, reference manuscripts and training




almost every central nervous system (1). Neuropeptidomic
studies (2–6) characterize neuropeptides using mass spectro-
metry and provide high-quality, empirical data on actual
neuropeptides. However, because the experimental discovery
or conﬁrmation of neuropeptides is time and labor intensive,
biochemical characterization of an animal’s neuropeptide
complement is not available for most species. The increasing
number of species that have or are being sequenced at the
genomic or transcriptomic level has motivated the develop-
ment of effective and accurate bioinformatics methodologies
to predict neuropeptides from sequence information.
A neuropeptide precursor mRNA sequence can be identiﬁed
from sequence information (7), and the resulting translated
protein sequence includes a signal peptide sequence and
one or multiple neuropeptides. An extensive and complica-
ted series of enzymatic processing steps, including cleavage
by prohormone or proprotein convertases and other post-
translational modiﬁcations, occur on the translated protein
sequence before the active neuropeptides are created. Prohor-
mone convertases are calcium-dependent serine proteases and
each has speciﬁc cleavage sites associated with the basic
amino acids Lys and Arg (8,9). Kexin, furin, and other pro-
hormone convertases, including PC1, PC2, PC4, PACE4, PC5
and PC7, have overlapping cleavage function, and multiple
prohormone convertases are also usually present simultan-
eously (8,9). Multiple prohormone convertases can cleave
the same site, and thus, overcome the functional loss of a
speciﬁc prohormone convertase. Consequently, the prediction
of the resulting neuropeptides from sequence information
alone can prove challenging.
While the cleavage motifs for furin and kexin have been
extensively studied, there is less information for other prohor-
mone convertases. General observations (often termed rules)
for cleavage recognition sites have been proposed (8), usually
without knowledge of the acting prohormone convertase.
However, these observations stem only from motifs that are
cleaved; non-cleaved motifs are typically ignored. Thus, many
of these observations are made without regard to cleavage
status. Southey et al. (10) predicted precursor cleavages
in insects, mammals, birds, ﬁsh and other species using a
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Although this approach identiﬁed most of the known cleav-
ages, it also had a high rate of false positive results (10).
Other approaches to predict neuropeptide cleavage sites
include logistic regression [(11,12), B. R. Southey,
A. B. Hummon, T. A. Richmond, S. L. Rodriguez-Zas and
J. V. Sweedler, manuscript submitted], and the artiﬁcial neural
network (13) available in the ProP application (http://www.
cbs.dtu.dk/services/ProP). Hummon et al. (11) predicted
cleavage sites in mollusk (Aplysia californica) precursors
using a logistic regression model on combinations of amino
acids and locations, and then applied the predictive function to
neuropeptide precursors from a range of organisms. This
approach was extended to mammalian precursors (12) and
toprecursorsidentiﬁedfromtheApismelliferaandDrosophila
melanogaster genomes (B. R. Southey, A. B. Hummon,
T. A. Richmond, S. L. Rodriguez-Zas and J. V. Sweedler,
manuscript submitted).
NeuroPred provides a uniﬁed interface to predict cleavage
sites byemployingmultipleapproaches, based onawide range
of precursors and species, as developed by Hummon et al.
(11), Amare et al. (12) and Southey et al. [(10), B. R. Southey,
A. B. Hummon, T. A. Richmond, S. L. Rodriguez-Zas and
J. V. Sweedler, manuscript submitted]. NeuroPred also has
the capability to calculate the mass of the neuropeptides
resulting from the predicted cleavages. Made widely available
as a web-based application, NeuroPred is a comprehensive
resource with which to explore neuropeptide precursor
processing and aid in the discovery and conﬁrmation of
new neuropeptides.
NEUROPRED
NeuroPred was written for the web using Python (http://www.
python.org) and can be accessed from http://neuroproteomics.
scs.uiuc.edu/neuropred.html. The main purpose of the Neuro-
Pred tool is to predict the cleavage sites of neuropeptide
precursors using logistic regression models trained on experi-
mentally veriﬁed cleavage information. In addition, model
accuracyindicatorsandneuropeptide masses canbecalculated
from the predicted cleavage sites.
The input required for NeuroPred is one or more sequences,
provided in the FASTA format, either entered directly into a
text box on the page, or uploaded via a text ﬁle. Available
user-options include ‘Model and Output Selection’, ‘Options
for Modeling and Mass Calculations’ and ‘Post-Translational
Modiﬁcations’ (Figure 1).
Model selection
The default model selection is the Known Motif (10); the other
models that can be selected are the Mollusk Basic and Mollusk
Complex (11), Mammalian (12) and two insect models, one
trained using the A.mellifera and the other the D.melanogaster
genomic information (B. R. Southey, A. B. Hummon,
T. A. Richmond, S. L. Rodriguez-Zas and J. V. Sweedler,
manuscript submitted). Multiple models can be used simul-
taneously to predict cleavage on the same sequence. Speciﬁc
details about the respective models, including training,
sequence information and ﬁnal terms, are provided by
Hummon et al. (11), Amare et al. (12) and Southey et al.
[(10), B. R. Southey, A. B. Hummon, T. A. Richmond,
S. L. Rodriguez-Zas and J. V. Sweedler, manuscript
submitted].
Output selection
Under the default option, ‘Predict Cleavage Sites Only’,
NeuroPred will only predict the cleavage sites by calculating
the probability of cleavage for each sequence entered for all
models selected. This step is completed for all output options.
After predicting the cleavage sites, NeuroPred will either
compute model accuracy statistics or perform mass calcula-
tions, according to the options selected.
Preprocessing
Prior to predicting the probability of cleavage, all precursor
sequences undergo a series of preprocessing steps, described
in detailed by Southey et al. (B. R. Southey, A. B. Hummon,
T. A. Richmond, S. L. Rodriguez-Zas and J. V. Sweedler,
manuscript submitted). The size of the window and location
of the cleavage site within the window are determined by the
model selected; the possibility of cleavage is only considered
at a basic site. Preprocessing components that can be changed
by the user are the length of the signal peptide and the min-
imum number of amino acids surrounding the cleavage site.
The length of the signal peptide can be speciﬁed by the user;
this length becomes the global value that is used for all the
precursor sequences. Alternatively, the length of the signal
peptide can be included in the FASTA label of each sequence,
which overrides the global value and may vary across
sequences. Examination of a wide range of precursors and
the structure of furin (14) suggests that a minimum number
of amino acids around the cleavage site are required for
cleavage to occur; therefore, the minimum number of amino
acids, preceding and following the cleavage site, can also be
speciﬁed by the user.
Cleavage prediction
Prediction of cleavage is achieved by calculating the probab-
ility of cleavage from the logistic regression (15) or Known
Motif models for each possible cleavage site. The predicted
probability of cleavage is compared with a predeﬁned thresh-
old and converted into cleavage or non-cleavage predictions.
A default threshold probability of 50% and a default conﬁd-
ence interval of 95% are displayed for the sites predicted to be
cleaved. The asymmetric conﬁdence interval reﬂects the non-
Gaussian nature of the predicted event and parameter space
of the probabilities between 0 and 1 (15). Both the threshold
probability and conﬁdence interval coverage can be modiﬁed
by the user.
Output of predicted cleavage
Upon selection of the basic ‘Predict Cleavage Sites Only’
option, the resulting output for each precursor is a diagram
that includes the sequence and the predicted cleavage sites
(similar to Figure 2). A ‘C’ below amino acid location com-
binations indicates that the predicted probability of cleavage
at that amino acid surpassed the user-deﬁned cleavage prob-
ability threshold. The predicted probability of cleavage and
associated 95% conﬁdence interval limits are displayed for
the amino acid location combinations predicted to be cleaved.
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with a ‘.’ to indicate a non-cleaved prediction. When multiple
models are selected, the predicted cleavage sites for each
approach are reported on the same diagram, thereby enabling
direct comparison of predicted cleavage sites.
Model accuracy statistics
NeuroPred can also assess the performance of the selected
approach. By comparing the predicted cleavages with user-
entered cleavage information, model accuracy statistics are
provided for each individual precursor sequence, and across
all precursor sequences entered.
These accuracy statistics are generated by selecting the
output option, ‘Predict Cleavage Sites and Calculate Model
Accuracy Statistics’. NeuroPred will calculate various model
accuracy statistics based on the predicted cleavage sites and
user-supplied, or ‘known’, cleavage information. The known
cleavage information is entered as a line following the
sequence where ‘0’ denotes no cleavage and ‘1’ denotes
cleavage. Note that when selecting this output option, if the
user-supplied information is not entered, or entered incor-
rectly, NeuroPred will predict the cleavage sites, but will
not provide the accuracy statistics.
The output from the model accuracy statistics selection is
similar to that from the ‘Predict Cleavage Sites Only’ option;
in addition, the user-entered cleavage information is also
represented in the output diagram (Figure 2) to aid in the
visualization of correct and incorrect predictions. Cleavage
sites that exceed the speciﬁed threshold probability are
denoted as either true or false predictions. In addition, the
probability and conﬁdence interval limits are provided for
knowncleavagesites thatdonotexceedthespeciﬁed threshold
probability.
The ‘Predict Cleavage Sites and Calculate Model Accuracy
Statistics’ option provides model accuracy statistics for
Figure 1. The NeuroPred input screen with the Chimpanzee NPFF sequence entered.
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probabilities ranging from 0.1 to 0.9. For each precursor,
model performance is evaluated using the number of pre-
dictions of correct cleavage (true positive result), incorrect
cleavage (false positive result), correct non-cleavage (true
negative result), and incorrect non-cleavage (false negative
result) across the length of the precursor. These values are
then summarized over all precursors entered. The adequacy of
the approach to model cleavage is evaluated across all pre-
cursors using the following statistics:
(i) Correct classification rate: number of correctly predicted
sites divided by the total number of sites.
(ii) Sensitivity (one minus false positive rate): number of
true positives divided by the total number of sites
cleaved.
(iii) Specificity (one minus false negative rate): number of
true negatives divided by the total number of sites not
cleaved.
(iv) Positive predictive power (proportion of sites that are
predicted to be cleaved that are true positives): number
of true positives divided by the total number of sites
predicted to be cleaved.
(v) Negative predictive power (proportion of sites that are
not predicted to be cleaved that are true negatives):
number of true negatives divided by the total number
of sites predicted to not be cleaved.
(vi) Correlation coefficient: Mathew’s correlation coefficient
(16) between observed and predicted cleavage.
(vii) Area under the receiver operator characteristic or ROC
curve relates sensitivity and 1-specificity (17). Area
values lower than 0.7 indicate poor model performance.
Peptide mass prediction
The mass of predicted peptides for multiple precursors can
be calculated by NeuroPred, where the masses of the peptides
are calculated using common neuropeptide post-translational
Figure 2. Partial NeuroPred output showing the predicted cleaved and non-cleaved sites and model accuracy statistics for the Chimpanzee NPFF precursor.
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of the intermediate and ﬁnal peptides and their associated
masses offers more complete information about the precursor-
derived peptides than a list of ﬁnal peptide masses.
The peptides are determined using the model results.
Speciﬁcally, basic sites are predicted as non-cleaved when
there is a consensus from the selected models for non-
cleavage. The sequence, after removal of the speciﬁed signal
peptide for each precursor, is cleaved at the remaining basic
sites to provide peptides of different lengths. In order to
account for any falsely predicted cleavages and different
model predictions, the peptides that are adjacent in the
sequence are joined (assuming that cleavage did not occur),
and these additional masses are included in the output. This
process of joining peptides can be extended up to, but not
including, complete sequence after removal of the speciﬁed
signal peptide.
Options to control the output of the mass prediction include:
the number of adjacent sites that can be joined, the range of
mass sizes, and the maximum number of amino acids of a
predicted peptide resulting from cleavage. The resulting
peptides are then further processed using a variety of possible
post-translational modiﬁcations—with the removal of ter-
minal basic amino acids, amidation and pyroglutamination
being selected by default. Other non-default modiﬁcations
can be selected. The selected post-translational modiﬁcations
are applied to each peptide where appropriate, resulting in
additional peptides. The average and monoisotopic masses
are calculated for every peptide.
The output (Figure 3) includes a list of peptides and the
mass calculation table. The columns of the mass calculation
table are the abbreviation of the sequence, the post-
translational modiﬁcations applied to that sequence, the
average and monoisotopic masses, and the full sequence.
The user can sort the list of peptides by the combination
of actual sequence location of the peptide and post-
translational modiﬁcation, or by either the average or
monoisotopic mass.
Figure 3. Predicted cleavage sites and the mass of predicted peptides after the default post-translation modifications for the Chimpanzee NPFF precursor.
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The non-experimentally conﬁrmed Chimpanzee NPFF pre-
cursor sequence reported by Southey et al. (10) is used
to demonstrate the use of the NeuroPred application. The
FASTA formatted sequence and postulated cleavage informa-
tion based on the human NPFF sequence are entered in the
corresponding text box in NeuroPred. The ‘Predict Cleavage
Sites and Calculate Model Accuracy Statistics’ option is selec-
ted (Figure 1) and all other settings are at the default values.
The default output is provided for the Chimpanzee NPFF,
including the predicted cleavage sites using the default Known
Motif approach and the model accuracy statistics (Figure 2).
The consensus cleavage sites in the diagram are identical to
the cleavage sites predicted by the default model because only
one model was selected. The diagram of the cleavage sites
indicates that two of the three cleavage sites are correctly
identiﬁed and one non-cleaved site is incorrectly predicted
as cleaved. The probabilities for the false negative site
(at position R92) and false positive site (at R88) are 0.89
and 0.0, respectively. The diagram shows that the third
amino acid preceding this false positive site is an Arg, thus,
fulﬁlling one of the motifs in the Known Motif model. The
false negative site, corresponding to the C-terminal region of
the NPAF peptide,occurs because there are no preceding basic
amino acids to fulﬁll any of the motifs in the Known Motif
model. This result for the NPFF precursor is consistent with
reports of variable location of cleavage across species (10).
The model accuracy statistics are presented; however, these
statistics are more useful when multiple predictive approaches
are selected.
Alternatively, the mass calculations can be obtained by
selecting the ‘Predict Cleavage Sites and Obtain Peptide
Masses’ option on the input screen. The mass calculations
from the Chimpanzee NPFF sequence (Figure 3) show a
wide range of possible peptides with different post-
translational modiﬁcations. The actual Chimpanzee NPFF
peptide is expected to have the sequence SQGFLFQPQRFa,
based on similarity to the human NPFF (10). One of the
peptides generated by cleavage of the NPFF precursor at
the predicted cleavage sites is SQGFLFQPQRFGR with a
predicted average mass of 1567.77 Da. Enzymes are expected
to remove the N-terminal Arg, resulting in a predicted aver-
age mass of 1411.58 Da. This peptide ends in Gly and so is
likely to be amidated, resulting in the ﬁnal predicted average
mass of 1353.547 Da. This mass is the one most likely to be
detected; however, the detection of any of these masses (or
MS/MS data) would suggest the presence of this peptide.
Thus, the approach implemented in NeuroPred would
have correctly predicted the two cleavage sites necessary to
generate NPFF from the precursor sequence studied.
AVAILABILITY
The NeuroPred tool, manual, reference publications and the
training sequences are available at http://neuroproteomics.scs.
uiuc.edu/neuropred.html.
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